Chapter X Nitric oxide-cGMP signaling in the rat brain

Handbook of Chemical Neuroanatomy

Volumn 17, Issue , 2000, Pages 355-415

  De Vente, J ^a   Steinbusch, H W M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350342733     PISSN: 09248196     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0924-8196(00)80064-0     Document Type: Article

References (246)

1. 2-/calmodulin-dependent cyclic GMP phosphodiesterase activity in granule neurons and astrocytes from rat cerebellum. Eur J Pharmacol 323 (1997) 119-125
2. Aitken P.G., Breese G.R., Dudek F.F., Edwards F., Espanol M.T., Larkman P.M., Lipton P., Newman G.C., Nowak T.S., Panizzon K.L., Raley-Susman K.M., Reid K.H., Rice M.E., Sarvey J.M., Schoepp D.D., Segal M., Tayor C.P., Teyler T.J., and Voulalas P.J. Preparative methods for brain slices: a discussion. J Neurosci Methods 59 (1995) 139-149
3. Allaerts W., Ubink R., De Vente J., Tuinhof R., Jenks B.G., and Roubos E.W. Nitric oxide synthase and background adaptation in Xenopus laevis. J Chem Neuroanat 14 (1997) 21-31
4. Allaerts W., De Vente J., Markerink-Van Ittersum M., Tuinhof R., and Roubos E.W. Topographical relationship between neuronal nitric oxide synthase immunoreactivity and cyclic 3′,5′-guanosine monophosphate accumulation in the brain of the adult Xenopus laevis. J Chem Neuroanat 15 (1998) 41-56
5. Aoki C., Rhee J., Lubin M., and Dawson T.M. NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre-and postsynaptic sites and in spines. Brain Res 750 (1997) 25-40
6. Ariano M.A. Distribution of components of the guanosine 3′, 5′-phosphate system in rat caudate-putamen. Neuroscience 3 (1983) 707-723
7. Ariano M.A. Muscarinic acetylcholine receptors are localized on striatal cyclic GMP-containing neurons. Brain Res 334 (1985) 152-156
8. Ariano M.A., and Matus A.I. Ultrastructural localization of cyclic GMP and cyclic AMP in rat striatum. J Cell Biol 91 (1981) 287-292
9. Ariano M.A., and Ufkes S.K. Cyclic nucleotide distribution within rat striatonigral neurons. Neuroscience 9 (1983) 23-29
10. Ariano M.A., Butcher L.L., and Appleman M.M. Cyclic nucleotides in the rat caudate-putamen complex: histochemical characterization and effects of deafferentation and kainic acid infusion. Neuroscience 5 (1980) 1269-1276
11. Ariano M.A., Lewicki J.A., and Brandwein H.J. Immunocytochemical localization of guanylate cyclase within neurons of rat brain. Proc Natl Acad Sci USA 79 (1982) 1316-1320
12. Baylor D. How photons start vision. Proc Natl Acad Sci USA 93 (1996) 560-565
13. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75 (1995) 725-748
14. Beavo J.A., and Reifsnyder D.H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Neurosci 11 (1990) 150-155
15. Berkelmans H.S., Schipper J., Hudson L., Steinbusch H.W.M., and De Vente J. cGMP immunocytochemistry in aorta, kidney, retina and brain tissues of the rat after perfusion with nitroprusside. Histochemistry 93 (1989) 143-148
16. Bicker G., Schmachtenberg O., and De Vente J. Geometric considerations of nitric oxide cyclic GMP signalling in the glomerular neuropil of the locust antennal lobe. Proc R Soc Lond B Biol Sci 264 (1997) 1177-1181
17. Biel M., Sautter A., Ludwig A., Hofmann F., and Zong X. Cyclic nucleotide-gated channels-mediators of NO: cGMP-regulated processes. Naumyn Schmiedebergs Arch Pharmacol 358 (1998) 140-144
18. Biggio G., and Guidotti A. Climbing fiber activation and 3′,5′-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellum. Brain Res 107 (1976) 365-373
19. Biggio G., Brodie B.B., Costa E., and Guidotti A. Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex. Proc Natl Acad Sci USA 74 (1977) 3592-3596
20. Billingsley M.L., Polli J.W., Balaban C.D., and Kincaid R.L. Developmental expression of calmodulin-dependent cyclic nucleotide phosphodiesterase in rat brain. Dev Brain Res 53 (1990) 253-263
21. 3H]cyclic GMP binding sites in the rat brain. J Chem Neuroanat 10 (1996) 287-293
22. Blokland A., De Vente J., Prickaerts J., Honig W., Markerink-Van Ittersum M., and Steinbusch H.W.M. Local inhibition of hippocampal nitric oxide synthase does not impair place learning in the Morris water escape task in rats. Eur J Neurosci 11 (1999) 223-232
23. Bloom F.E., Hoffer B.J., Battenberg E.R., Siggins G.R., Steiner A.L., Parker C.W., and Wedner H.J. Adenosine 3′,5′-monophosphate is localized in cerabellar neurons: immunofluorescence evidence. Science 177 (1972) 436-438
24. 3H]cGMP binding sites in the rat brain. Brain Res 763 (1997) 1-13
25. Boxall A.R., and Garthwaite J. Long-term depression in rat cerebellum requires both NO synthase and NO-sensitive guanylyl cyclase. Eur J Neurosci 8 (1996) 2209-2212
26. Bradley J., Zhang Y., Bakin R., Lester H.A., Ronnett G.V., and Zinn K. Functional expression of the heteromeric 'olfactory' cyclic nucleotide-gated channel in the hippocampus: a potential effector of synaptic plasticity in brain neurons. J Neurosci 17 (1997) 1993-2005
27. Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86 (1989) 9030-9033
28. Bredt D.S., and Snyder S.H. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13 (1994) 301-313
29. Bredt D.S., Ferris C.D., and Snyder S.H. Nitric oxide synthase regultory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase: identification of flavin and calmodulin binding sites. J Biol Chem 267 (1992) 10976-10981
30. Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., Huang F., Xia H., Peters M.F., Froehner S.C., and Bredt D.S. Interaction of nitric oxide synthase with the synaptic density protein PSD-95 and α-1 syntrophin mediated by PDZ motifs. Cell 84 (1996) 757-767
31. Brien J.F., Reynolds J.D., Cunningham M.A., Parr A.M., Waddock S., and Kalisch B.E. Nitric oxide synthase activity in the hippocampus, frontal cerebral cortex, and cerebellum of the guinea pig: ontogeny and in vitro ethanol exposure. Alcohol 12 (1995) 329-333
32. Bunn S.J., Garthwaite J., and Wilkin G.P. Guanylate cyclase activities in enriched preparations of neurones, astroglia and a synaptic complex isolated from rat cerebellum. Neurochem Int 8 (1986) 179-185
33. Burgal M., Jorda A., and Grisolia S. Effects of N-acetyl aspartate, aspartate, and glutamate on cAMP and cGMP levels in developing rat cerebral cortex. J Neurochem 38 (1982) 1498-1500
34. Burgunder J.M., and Cheung P.T. Expression of soluble guanylyl cyclase gene in adult rat brain. Eur J Neurosci 6 (1994) 211-217
35. Burnett A.L., Nelson R.J., Calvin D.C., Liu J.X., Demas G.E., Klein S.L., Kriegsfeld L.J., Dawson V.L., Dawson T.M., and Snyder S.H. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 2 (1996) 288-296
36. Burns F., Rodger I.W., and Pyne N.J. The catalytic subunit of protein kinase-A triggers activation of the type-V cyclic GMP-specific phosphodiesterase from guinea-pig lung. Biochem J 283 (1992) 487-491
37. Buwalda B., Nyakas C., Gast J., Luiten P.G.M., and Schmidt H.H.H.W. Aldehyde fixation differentially affects distribution of diaphorase activity but not of nitric oxide synthase immunoreactivity in rat brain. Brain Res Bull 38 (1995) 467-473
38. Chan-Palay V., and Palay S.L. Immunocytochemical localization of cyclic GMP: light and electron microscope evidence for involvement of neuroglia. Proc Natl Acad Sci USA 76 (1979) 1485-1488
39. Chen D., Hurst W.J., Ding J.M., Faiman L.E., Mayer B., and Gilette M.U. Localization and characterization of nitric oxide synthase in the rat suprachiasmatic nucleus: evidence for a nitrergic plexus in the biological clock. J Neurochem 68 (1997) 855-861
40. Cherry J.A., and Davis R.L. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407 (1999) 287-301
41. Chiang L.W., Schweizer F.E., Tsien R.W., and Schulman H. Nitric oxide synthase expression in single hippocampal neurons. Mol Brain Res 27 (1994) 183-188
42. Crepel F., Audinat E., Daniel H., Hemart N., Jaillard D., Rossier J., and Lambolez B. Cellular locus of the nitric oxide-synthase involved in cerebellar long-term depression induced by high external potassium concentration. Neuropharmacology 33 (1994) 1399-1405
43. Cumming R. Immunocytochemistry of second messenger systems. Trends Neurosci 4 (1981) 202-204
44. Cumming R., Eccleston D., and Steiner A.L. Immunohistochemical localization of cyclic GMP in rat cerebellum. J Cyclic Nucleotide Res 3 (1977) 275-282
45. Cumming R., Arbuthnott G., and Steiner A.L. Characterization of immunofluorescent cyclic GMP-positive fibers in the central nervous system. J Cyclic Nucleotide Res 5 (1979) 463-467
46. Cumming R., Dickison S., and Arbuthnott G. Cyclic nucleotide losses during tissue processing for immunocytochemistry. J Histochem Cytochem 28 (1980) 54-55
47. Daniel H., Hemart N., Jaillard D., and Crepel F. Long-term depression requires nitric oxide and guanosine 3′:5′ cyclic monophosphate production in rat cerebellar Purkinje cells. Eur J Neurosci 5 (1993) 1079-1082
48. Davidoff M.S., Middendorf R., Mayer B., De Vente J., Koesling D., and Holstein A.F. Nitric oxide/cGMP pathway components in the Leydig cells of the human testis. Cell Tissue Res 287 (1997) 170-171
49. Davis C.W., and Kuo J.F. Ontogenetic changes in levels of phosphodiesterase for adenosine 3′:5′-monophosphate and guanosine 3′:5′-monophosphate in the lung. liver, brain and heart from guinea pigs. Biochim Biophys Acta 444 (1976) 554-562
50. De Vente J., and Steinbusch H.W.M. On the stimulation of soluble and particulate guanylate cyclase in the rat brain and the involvement of nitric oxide as studied by cGMP immunocytochemistry. Acta Histochem 92 (1992) 13-38
51. De Vente J., and Steinbusch H.W.M. cGMP-immunocytochemistry. In: Rayne R.J. (Ed). Neurotransmitter Methods. Methods in Molecular Biology. Vol 72. Totowa, NJ: Humana Press (1997) 125-143
52. De Vente J., Garssen J., Tilders F.J.H., Steinbusch H.W.M., and Schipper J. Single cell quantitative immunocytochemistry of cyclic GMP in the superior cervical ganglion of the rat. Brain Res 411 (1987) 120-128
53. De Vente J., Steinbusch H.W.M., and Schipper J. A new approach to immunocytochemistry of 3′,5′-cyclic guanosine monophosphate: preparation, specificity, and initial application of a new antiserum against formaldehyde-fixed 3′,5′-cyclic guanosine monophosphate. Neuroscience 22 (1987) 361-373
54. De Vente J., Bol J.G.J.M., and Steinbusch H.W.M. Cyclic GMP-producing atrial natriuretic factor-responding cells in the rat brain: an immunocytochemical study. Eur J Neurosci 1 (1989) 436-460
55. De Vente J., Bol J.G.J.M., and Steinbusch H.W.M. Localization of cGMP in the cerebellum of the adult rat: an immunohistochemical study. Brain Res 504 (1989) 332-337
56. De Vente J., Schipper J., and Steinbusch H.W.M. Formaldehyde fixation of cGMP in distinct cellular pools and their recognition by different cGMP-antisera. An immunocytochemical study into the problem of serum specificity. Histochemistry 91 (1989) 401-412
57. De Vente J., Bol J.G.J.M., Berkelmans H.S., Schipper J., and Steinbusch H.W.M. Immunocytochemistry of cGMP in the cerebellum of the immature, adult, and aged rat: the involvement of nitric oxide. A micropharmacological study. Eur J Neurosci 2 (1990) 845-862
58. De Vente J., Hopkins D.A., Markerink-Van Ittersum M., and Steinbusch H.W.M. Effects of the 3′, 5′-phosphodiesterase inhibitors isobutylmethylxanthine and zaprinast on NO-mediated cGMP accumulation in the hippocampus slice preparation: an immunocytochemical study. J Chem Neuroanat 10 (1996) 241-248
59. De Vente J., Hopkins D.A., Markerink-Van Ittersum M., Emson P.C., Schmidt H.H.H.W., and Steinbusch H.W.M. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience 87 (1998) 207-241
60. De Vente J., Hopkins D.A., Markerink-Van Ittersum M., and Steinbusch H.W.M. Nitric oxide-mediated cGMP production in the islands of Calleja in the rat. Brain Res 789 (1998) 175-178
61. De Vente J., Markerink-Van Ittersum M., Van Staveren W., and Steinbusch H.W.M. YC-1 potentiates nitric oxide activation of soluble guanylyl cyclase in rat brain slices: characterization of the cGMP response in cholinergic, GABAergic and glutamatergic neurons. Soc Neurosci Abstr 481 (1999) 12
62. De Vente J., Markerink-Van Ittersum M., Van Abeelen J., Emson P.C., Axer H., and Steinbusch H.W.M. NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis. Eur J Neurosci 12 (2000) 507-519
63. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411 (1999) 334-350
64. Derer P., and Derer M. Ontogenesis of NADPH-diaphorase neurons in the mouse forebrain. Neurosci lett 152 (1993) 21-24
65. Detre J.A., Nairn A.C., Aswad D.W., and Greengard P. Localization in mammalian brain of G-substrate, a specific substrate for guanosine 3′,5′-cyclic monophosphate-dependent protein kinase. J Neurosci 4 (1984) 2843-2849
66. Dierks E.A., Hu S., Vogel K.M., Yu A.E., Spiro T.G., and Burstyn J.N. Demonstration of the role of scission of the proximal histidine-iron bond in the activation of soluble guanylyl cyclase through metalloporphyrin substitution studies. J Am Chem Soc 119 (1997) 7316-7323
67. Diket A.L., Pierce M.R., Munshi U.K., Voelker C.A., Eloby-Childress S., Greenberg S.S., Zhang X.J., Clark D.A., and Miller M.J.S. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 171 (1994) 1243-1250
68. Dinerman J.L., Dawson T.M., Schell M.J., Snowman A., and Snyder S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci USA 91 (1994) 4214-4218
69. Egberongbe Y.I., Gentleman S.M., Falkai P., Bogerts B., Polak J.M., and Roberts G.W. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59 (1994) 561-578
70. El-Husseini A., Bladen C., and Vincent S.R. Molecular characterization of a type II cyclic GMP-dependent protein kinase expressed in the rat brain. J Neurochem 64 (1995) 2814-2817
71. El-Husseini A., Bladen C., and Vincent S.R. Expression of the olfactory cyclic nucleotide gated channel (CNG1) in the rat brain. Neuroreport 6 (1995) 1459-1463
72. Eliasson M.J.L., Blackshaw S., Schell M.J., and Snyder S.H. Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci USA 94 (1997) 3396-3401
73. Endoh M., Maiese K., and Wagner J.A. Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience 63 (1994) 679-689
74. Fedele E., and Raiteri M. In vivo studies of the cerebral glutamate receptor NO/cGMP pathway. Prog Neurobiol 58 (1999) 89-120
75. Fedele E., Bisaglia M., and Raiteri M. d-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis. Naunyn Schmiedebergs Arch Pharmacol 355 (1997) 43-47
76. Feelisch M., Kotsonis P., Siebe J., Clement C., and Schmidt H.H.H.W. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Mol Pharmacol 56 (1999) 243-253
77. Ferrendelli J.A. Distribution and regulation of cyclic GMP in the central nervous system. Adv Cyclic Nucleotide Res 9 (1978) 453-464
78. Ferrendelli J.A., Steiner A.I., McDougal D.B., and Kipnis D.M. The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellum. Biochem Biophys Res Commun 41 (1970) 1061-1067
79. Ferrendelli J.A., Kinscherf D.A., and Chang M.M. Regulation of levels of guanosine cyclic 3′,5′-monophosphate in the central nervous system: effects of depolarizing agents. Mol Pharmacol 9 (1973) 445-454
80. Finney E.M., and Shatz C.J. Establishment of patterned thalamocortical connections does not require nitric oxide synthase. J Neurosci 18 (1998) 8826-8838
81. Fisher D.A., Smith J.F., Pillar J.S., Denis S.H.S., and Cheng J.B. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 273 (1998) 15559-15564
82. Friebe A., Schultz G., and Koesling D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15 (1996) 6863-6868
83. Friebe A., Müllershausen F., Smolenski A., Walter U., Schultz G., and Koesling D. YC-1 potentiates nitric oxideand carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol 54 (1998) 962-967
84. Furuyama T., Inagaki S., and Takagi H. Localizations of α1 and β1 subunits of soluble guanylate cyclase in the rat brain. Mol Brain Res 20 (1993) 335-344
85. Furuyama T., Iwahashi Y., Tano Y., Takagi H., and Inagaki S. Localization of 63-kDa calmodulin-stimulated phosphodiesterase mRNA in the rat brain by in situ hybridization histochemistry. Mol Brain Res 26 (1994) 331-336
86. Galle J., Zabel U., Hatzelmann A., Wagner B., Wanner C., and Schmidt H.H.H.W. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol 127 (1999) 195-203
87. Garbers D.L., and Lowe D.G. Guanylyl cyclase receptors. J Biol Chem 269 (1994) 30741-30744
88. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14 (1991) 60-67
89. Garthwaite J., and Boulton C.L. Nitric oxide signalling int he central nervous system. Annu Rev Physiol 57 (1995) 683-706
90. Garthwaite J., and Garthwaite G. Cellular origins of cyclic GMP responses to excitatory amino acid receptor agonists in rat cerebellum in vitro. J Neurochem 48 (1987) 29-39
91. Garthwaite J., Woodham P.L., Collins M.J., and Balasz R. On the preparation of brain slices: morphology and cyclic nucleotides. Brain Res 173 (1979) 373-377
92. Garthwaite J., Charles S.L., and Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 (1988) 385-388
93. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., and Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one. Mol Pharmacol 48 (1995) 184-188
94. Giuli G., Scholl U., Bulle F., and Guellaën G. Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett 304 (1992) 83-88
95. Giuili G., Luzi A., poyard M., and Guellaën G. Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny. Dev Brain Res 81 (1994) 269-283
96. Gonzalez-Hernandez T., Conde-Sindin M., Gonzalez-Gonzalez B., Mantolan-Sarmiento B., Perez-Gonzalez H., and Meyer G. Postnatal development of NADPH-diaphorase activity in the superior colliculus and the ventral lateral geniculate nucleus of the rat. Dev Brain Res 76 (1993) 141-145
97. Gonzalez-Hernandez T., Gonzalez-Gonzalez B., Mantolan-Sarmiento B., Mendez-Medina R., Ferres-Torres R., and Meyer G. Transient NADPH-diaphorase activity in motor nuclei of the foetal human brain stem. Neuroreport 5 (1994) 758-760
98. Gregg A.R., Schauer A., Shi O., Liu Z., Lee C.G.L., and O'Brien W.E. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol 275 (1998) H2319-H2324
99. Gudi T., Lohmann S.M., and Pilz R.B. Regulation of gene expression by cyclic GMP-dependent kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal. Mol Cell Biol 17 (1997) 5244-5254
100. Guipponi M., Scott H.S., Kudoh J., Kawasaki K., Shibuya K., Shintani A., Asakawa S., Chen H., Lalioti M.D., Rossier C., Minoshima S., Shimizu N., and Antonarakis S.E. Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative spicing of mRNA transcripts, genomic structure and sequence. Hum Genet 103 (1998) 386-392
101. Hakim T.S., Sugimori K., Camporesi E.M., and Anderson G. Half-life of nitric oxide in aqueous solutions with and without haemoglobin. Physiol Meas 17 (1996) 267-277
102. Hartell N.A. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. Neuroreport 5 (1994) 833-836
103. Hartell N.A. Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression. J Neurosci 16 (1996) 2881-2890
104. Harteneck C., Koesling D., Söling A., Schulz G., and Böhme E. Expression of soluble guanylyl cyclase. Catalytic activity requires two enzyme subunits. FEBS Lett 272 (1990) 221-223
105. Hawkins R.D., Zhuo M., and Arancio O. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation. J Neurosci 25 (1994) 652-665
106. Herbison A.E., Simonian S.X., Norris P.J., and Emson P.C. Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat. J Neuroendocrinol 8 (1996) 73-82
107. Hermenegildo C., Montoliu C., Llansola M., Munoz M.D., Gaztelu J.M., Minana M.D., and Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci 10 (1998) 3201-3209
108. Holzman D.M., Lee S., Li Y., Chua-Couzens J., Xia H., Bredt D.S., and Mobley W.C. Expression of neuronal-NOS in developing basal forebrain cholinergic neurons: regulation by NGF. Neurochem Res 21 (1996) 861-868
109. Hopkins D.A., Steinbusch H.W.M., Markerink-Van Ittersum M., and De Vente J. Nitric oxide synthase, cGMP, and NO-mediated cGMP production in the olfactory bulb of the rat. J Comp Neurol 375 (1996) 641-658
110. Houslay M.D. Adaptation of cyclic AMP signalling processes: a dual role for cyclic AMP phosphodiesterases. Semin Cell Dev Biol 9 (1998) 161-167
111. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., and Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 (1993) 1273-1286
112. Ignarro L.J. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol 26 (1989) 63-76
113. Ignarro L.J. Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins. Adv Pharmacol 26 (1994) 35-65
114. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., and Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 90 (1993) 8103-8107
115. Juilfs D.M., Fülle H.J., Zhao A.Z., Houslay M.D., Garbers D.L., and Beavo J.A. A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci USA 94 (1997) 3388-3395
116. Kant G.J., Muller T.W., Lenox R.H., and Meyerhoff J.L. In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in rat brain regions and pituitary. Biochem Pharmacol 29 (1980) 1891-1896
117. Kaupp U.B. Family of cyclic nucleotide gated ion channels. Curr Opin Neurobiol 5 (1995) 434-442
118. Kebabian J.W., Bloom F.E., Steiner A.L., and Greengard P. Neurotransmitters increase cyclic nucleotides in postganglionic neurons: immunocytochemical demonstration. Science 190 (1975) 157-159
119. Keilhoff G., Seidel B., Noack H., Tischmeyer W., Stanek D., and Wolf G. Patterns of nitric oxide synthase at the messenger RNA and protein levels during early rat brain development. Neuroscience 75 (1996) 1193-1201
120. Kharitonov V.G., Sundquist A.R., and Sharma V.S. Kinetics of nitric oxide autoxidation in aqueous solution. J Biol Chem 269 (1994) 5881-5883
121. Kincaid R.L., Balaban C.D., and Billingsley M.L. Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. Proc Natl Acad Sci USA 84 (1987) 1118-1122
122. Klein S.L., Carnovale D., Burnett A.L., Wallach E.E., Zacur H.A., Crone J.K., Dawson V.L., Nelson R.J., and Dawson T.M. Impaired ovulation in mice with targeted deletion of the neuronal isoform of nitric oxide synthase. Mol Med 4 (1998) 658-664
123. Knowles R.G., Palacios M., Palmer R.M.J., and Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 86 (1989) 5159-5162
124. Ko F.N., Wu C.C., Kuo S.C., Lee F.Y., and Teng C.M. YC-1, a novel activator of platelet guanylate cyclase. Blood 84 (1994) 4226-4233
125. Koesling D. Modulators of soluble guanylyl cyclase. Naunyn Schmiedebergs Arch Pharmacol 358 (1998) 123-126
126. Koesling D., Harteneck C., Humbert P., Bosserhoff A., Frank R., Schultz G., and Böhme E. The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. FEBS Lett 266 (1990) 128-132
127. Koga T., Yoshida Y., Cai J.Q., Islam M.O., and Imai S. Purification and characterization of 240-kDa cGMP-dependent protein kinase substrate of vascular smooth muscle. Close resemblance to inositol 1,4,5-trisphosphate. J Biol Chem 269 (1994) 11640-11647
128. Koleshnikov Y.A., Pan Y.X., Babey A.M., Jain S., Wilson R., and Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 94 (1997) 8220-8225
129. Komalavilas P., and Lincoln T.M. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem 271 (1996) 21933-21938
130. Kornau H.C., Schenker L.T., Kennedy M.B., and Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269 (1995) 1737-1740
131. Kotera J., Fujishige K., Yuasa K., and Omori K. Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem Biophys Res Commun 261 (1999) 551-557
132. Kummer W., Behrends S., Schwarzlmüller T., Fischer A., and Koesling D. Subunits of soluble guanylyl cyclase in rat and guinea-pig sensory ganglia. Brain Res 721 (1996) 191-195
133. Laitinen J.T., Laitinen K.S.M., Tuomisto L., and Airaksinen M.M. Differential regulation of cyclic GMP levels in the frontal cortex and the cerebellum of anesthetized rats by nitric oxide: an in vivo microdialysis study. Brain Res 668 (1994) 117-121
134. Lancaster J.R. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91 (1994) 8137-8141
135. A receptors. Mol Brain Res 42 (1996) 131-134
136. 2+ transients. Neuron 15 (1995) 407-415
137. 2+ in the induction of cerebellar long-term depression. Neuron 18 (1997) 1025-1038
138. Lewicki J.A., Brandwein H., Walsman S.A., and Murad F. Purified guanylate cyclase: characterization, iodination and preparation of monoclonal antibodies. J Cyclic Nucleotide Res 6 (1980) 283-296
139. Li J., Chen S., Lin R.C.S., and Smith S.S. Cerebellar nitric oxide synthase is expressed within granule cell patches innervated by specific mossy fiber terminals: a developmental profile. Dev Neurosci 19 (1996) 274-282
140. Linden D.J., Dawson T.M., and Dawson V.L. An evaluation of the nitric oxide/cGMP/cGMP-dependent protein kinase cascade in the induction of cerebellar long-term depression in culture. J Neurosci 15 (1995) 5098-5105
141. Liu H., Force T., and Bloch K.D. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells. J Biol Chem 272 (1997) 6038-6043
142. 2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA 95 (1998) 2175-2179
143. Lochhead A., Nekrasova E., Arshavsky V.Y., and Pyne N.J. The regulation of the cGMP-binding cGMP phosphodiesterase by proteins that are immunologically related to γ subunit of the photoreceptor cGMP phosphodiesterase. J Biol Chem 272 (1997) 18397-18403
144. Lohmann S.M., Walter U., Miller P.E., Greengard P., and DeCamilli P. Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc Natl Acad Sci USA 78 (1981) 653-657
145. Loughney K., Snyder P.B., Uher L., Rosman G.J., Ferguson K., and Florio V.A. Isolation and characterization of PDE10A, a novel human 3′,5′-cyclic nucleotide phosphodiesterase. Gene 234 (1999) 109-117
146. Ludvig N., Burmeister V., Jobe P.C., and Kincaid R.L. Electron microscopic immunocytochemical evidence that the calmodulin-dependent cyclic nucleotide phosphodiesterase is localized predominantly at postsynaptic sites in the rat brain. Neuroscience 44 (1991) 491-500
147. Luo D., Leung E., and Vincent S.R. Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study. J Neurosci 14 (1994) 263-271
148. Mao C.C., Guidotti A., and Landis S. Cyclic GMP: reduction of cerebellar concentrations in nervous mutant mice. Brain Res 90 (1975) 335-339
149. Markerink-Van Ittersum M., Steinbusch H.W.M., and De Vente J. Region-specific developmental patterns of atrial natriuretic factor- and nitric oxide-activated guanylyl cyclases in the postnatal frontal rat brain. Neuroscience 78 (1997) 571-587
150. Matsumoto T., Nakane M., Pollock J.S., Kuk J.E., and Förstermann U. A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative. Neurosci Lett 155 (1993) 61-64
151. Matsumoto T., Pollock J.S., Nakane M., and Förstermann U. Developmental changes of cytosolic and particulate nitric oxide synthase in rat brain. Dev Brain Res 73 (1993) 199-203
152. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaën G., and Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J Neurosci 12 (1992) 3350-3360
153. 2+. J Neurochem 59 (1992) 2024-2029
154. Mikami T., Kusakabe T., and Suzuki N. Tandem organization of Medaka fish soluble guanylyl cyclase α1 and β1 subunit genes. Implications for coordinated transcription of two subunit genes. J Biol Chem 274 (1999) 18567-18573
155. Mollace V., Rodino P., Massoud R., Rotiroti D., and Nisticq G. Age-dependent changes of NO synthase activity in the rat brain. Biochem Biophys Res Commun 215 (1995) 822-827
156. Moreno-Lopez B., Estrada C., and Escudero M. Mechanisms and action and targets of nitric oxide in the oculomotor system. J Neurosci 18 (1998) 10672-10679
157. Moses M.A., Szabo E.I., and Terner C. Control of low Km cyclic adenosine 3′,5′-monophosphate phosphodiesterase in prostate and heart of adult and aged rats. Mech Ageing Dev 39 (1987) 103-112
158. Mundel P., Gambaryan S., Bachmann S., Koesling D., and Kriz W. Immunolocalization of soluble guanylyl cyclase subunits in rat kidney. Histochemistry 103 (1995) 75-79
159. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv Pharmacol 26 (1994) 19-33
160. Murad F., Mittal C.K., Arnold W.P., Katsuki S., and Kimura H. Guanylate cyclase: activation by azide, nitro-compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 9 (1978) 145-158
161. Nakane M., and Murad F. Cloning of guanylyl cyclase isoforms. Adv Pharmacol 26 (1994) 7-18
162. Nakane M., Ichikawa M., and Deguchi T. Light and electron microscopic demonstration of guanylate cyclase in rat brain. Brain Res 273 (1983) 9-15
163. Niethammer M., Kim E., and Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J Neurosci 16 (1996) 2157-2163
164. O'Dell T.J., Hawkins R.D., Kandel E.R., and Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88 (1991) 11285-11289
165. Ohyu J., and Takashima S. Developmental characteristics of neuronal nitric oxide synthase (nNOS) immunoreactive neurons in fetal to adolescent human brains. Dev Brain Res 110 (1998) 193-202
166. Olgilvie P., Schilling K., Billingsley M.L., and Schmidt H.H.H.W. Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis. FASEB J 9 (1995) 799-806
167. Oltmans G.A., Moss L.E., Lorden J.F., and Beales M. Acute and chronic effects of climbing fiber lesions on cerebellar cyclic guanosine monophosphate. Brain Res 437 (1987) 183-188
168. Ortez R.A., Sikes R.W., and Sperling H.G. Immunohistochemical localization of cyclic GMP in goldfish retina. J Histochem Cytochem 28 (1980) 263-279
169. Papapetropoulos A., Marczin N., Mora G., Milici A., Murad F., and Catravas J.D. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension 26 (1995) 696-704
170. Parkinson S.J., Jovanovic A., Jovanovic S., Wagner F., Terzic A., and Waldman S.A. Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. Biochemistry 38 (1999) 6441-6448
171. Peunova N., and Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375 (1995) 68-73
172. Pierce R.L., Pierce M.R., Liu H., Kadowitz P.J., and Miller M.J.S. Limb reduction defects after prenatal inhibition of nitric oxide synthase in rats. Pediatr Res 38 (1995) 905-911
173. Pineda J., Kogan J.H., and Aghajanian G.K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J Neurosci 16 (1996) 1389-1399
174. Polli J.W., and Kincaid R.L. Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 14 (1994) 1251-1261
175. Prickaerts J., De Vente J., Markerink-Van Ittersum M., and Steinbusch H.W.M. Behavioral, neurochemical and neuroanatomical effects of chronic postnatal N-nitro-L-arginine methyl ester treatment in neonatal and adult rats. Neuroscience 87 (1998) 181-195
176. Puri S.K., and Volicer L. Age-related changes in cyclic nucleotide levels in rat brain regions. Mech Ageing Dev 15 (1981) 239-242
177. Reinhardt R.R., and Bondy C.A. Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain. Neuroscience 72 (1996) 567-578
178. Repaske D.R., Corbin J.G., Conti M., and Goy M.F. A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase is highly expressed in the limbic system of the rat brain. Neuroscience 56 (1993) 673-686
179. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Morenos V., Martinez-Murillo R., and Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci 345 (1994) 175-221
180. Roskams A.J., Bredt D.S., Dawson T.M., and Ronnett G.V. Nitric oxide mediates the formation of synaptic connections in developing and regenerating olfactory receptor neurons. Neuron 13 (1994) 289-299
181. Rubin E.H., and Ferrendelli J.A. Distribution and regulation of cyclic nucleotide levels in cerebellum, in vivo. J Neurochem 29 (1977) 43-51
182. Sakagami H., Sawamura Y., and Kondo H. Synchronous patchy pattern of gene expression for adenylyl cyclase and phosphodiesterase but discrete expression for G-protein in developing rat striatum. Mol Brain Res 33 (1995) 185-191
183. Sakaue M., Kuno T., and Tanaka C. Novel type of monoclonal antibodies against cyclic GMP and application to immunocytochemistry of rat brain. Jpn J Pharmacol 48 (1988) 47-56
184. Samama B., Chateau D., and Boehm N. Expression of NADPH-diaphorase in the rat forebrain during development. Neurosci Lett 184 (1995) 204-207
185. Schmidt H.A., and Pehl U. Regional specific effects of nitric oxide donors and cGMP on the electrical activity of neurons in the rat spinal cord. J Chem Neuroanat 10 (1996) 197-201
186. Schmidt H.H.H.W. NO, CO and OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett 307 (1992) 102-107
187. Schmidt H.H.H.W., Gagne G.D., Nakane M., Pollock J.S., Miller M.F., and Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH-diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem 40 (1992) 1439-1456
188. Schmidt M.J., and Thornberry J.F. Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats. Brain Res 139 (1978) 169-177
189. Shibuki K., and Kimura S. Dynamic properties of nitric oxide release from parallel fibers in rat cerebellar slices. J Physiol Lond 498 (1997) 443-452
190. Shibuki K., and Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349 (1991) 326-328
191. Shimouchi A., Janssens S.P., Bloch D.B., Zapol W.M., and Bloch D.B. cAMP regulates soluble guanylate cyclase β1 subunit gene expression in RLF-6 rat fetal long fibroblasts. Am J Physiol 265 (1993) L456-L461
192. Shuttleworth C.W., Xue C., Ward S.M., De Vente J., and Sanders K.M. Immunohistochemical localization of 3′,5′-cyclic guanosine monophosphate in the canine proximal colon: responses to nitric oxide and electrical stimulation of enteric inhibitory neurons. Neuroscience 56 (1993) 513-522
193. Smigrodzki R., and Levitt P. The α1 subunit of soluble guanylyl cyclase is expressed prenatally in the rat brain. Dev Brain Res 97 (1996) 226-234
194. Smoake J.A., Song S.Y., and Cheung W.Y. Cyclic 3′,5′-nucleotide phosphodiesterase, distribution and developmental changes of the enzyme and its protein activator in mammalian tissues and cells. Biochim Biophys Acta 341 (1974) 402-411
195. Smolenski A., Burkhardt A.M., Eigenthaler M., Butt E., Gambaryan S., Lohmann S.M., and Walter U. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn Schmiedebergs Arch Pharmacol 358 (1998) 134-139
196. Soderling S.H., Bayuga S.J., and Beavo J.A. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J Biol Chem 273 (1998) 15553-15558
197. Soderling S.H., Bayuga S.J., and Beavo J.A. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci USA 96 (1999) 7071-7076
198. Sonnenburg W.K., Mullaney P.J., and Beavo J.A. Molecular cloning of a cyclic GMP-simulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants. J Biol Chem 266 (1991) 17655-17661
199. Sonnenburg W.K., Seger D., and Beavo J.A. Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue specific expression of structurally related isoforms. J Biol Chem 268 (1993) 645-652
200. Southam E., and Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32 (1993) 1267-1277
201. Southam E., Morris R., and Garthwaite J. Sources and targets of nitric oxide in rat cerebellum. Neurosci Lett 137 (1992) 241-244
202. Steinbusch H.W.M., Verhofstad A., and Joosten H.W.J. Localization of serotonin in the central nervous system by immunohistochemistry: description of a specific and sensitive technique and some applications. Neuroscience 3 (1978) 811-819
203. Steinbusch H.W.M., Verhofstad A., Penke B., Varga J., and Joosten H.W.J. Immunohistochemical characterization of monoamine-containing neurons in the central nervous system by antibodies to serotonin and noradrenaline. A study in the rat and the lamprey (Lampetra fluviatilis). Acta Histochem Suppl XXIV (1981) 107-122
204. Steinbusch H.W.M., Verhofstad A., and Joosten H.W.J. Antibodies to serotonin for neuroimmuno-cytochemical studies on the central nervous system. Methodological aspects and applications. In: Cuello A.C. (Ed). Neuroimmunocytochemistry, IBRO Handbook Series: Methods in the Neurosciences Vol. 2 (1983), Wiley, Chichester 193-214
205. Steiner A.L., Parker C.W., and Kipnis D.M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem 247 (1972) 1106-1113
206. Steiner A.L., Ong S., and Wedner H.J. Cyclic nucleotide immunocytochemistry. Adv Cyclic Nucleotide Res 7 (1976) 115-155
207. Stone J.R., and Marletta M.A. Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry 34 (1995) 14668-14674
208. Stone J.R., and Marletta M.A. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 5 (1998) 255-261
209. Tanaka J., Markerink-Van Ittersum M., Steinbusch H.W.M., and De Vente J. Nitric oxide-mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia 19 (1997) 286-297
210. Tenorio F., Giraldi-Guimarães A., and Mendez-Otero R. Developmental changes of nitric oxide synthase in the rat superior colliculus. J Neurosci Res 42 (1995) 633-637
211. Tomic D., Zobundzija M., and Meaugorac M. Postnatal development of nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) positive neurons in rat prefrontal cortex. Neurosci Lett 170 (1994) 217-220
212. Traylor T.G., and Sharma V.S. Why NO?. Biochemistry 31 (1992) 2847-2849
213. Truman J.W., De Vente J., and Ball E.E. Nitric oxide-sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. Development 122 (1996) 3949-3958
214. Tsai A.L. How does NO activate hemeproteins?. FEBS Lett 341 (1994) 141-145
215. Tsou K., Snyder G.L., and Greengard P. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra. Proc Natl Acad Sci USA 90 (1993) 3462-3465
216. Tsukada M., Yamazaki Y., and Koizumi A. Changes in nitric oxide synthase activities in the cerebellum during development and aging of C57BL/6 mice. Tohoku J Exp Med 176 (1995) 69-74
217. Uhler M.D. Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. J Biol Chem 268 (1993) 13586-13591
218. Vaid R.R., Yee B.K., Rawlins J.N.P., and Totterdell S. NADPH-diaphorase reactive pyramidal neurons in Ammon's horn and the subiculum of the rat hippocampal formation. Brain Res 733 (1996) 31-40
219. Vaid R.R., Yee B.K., Rawlins J.N.P., and Totterdell S. A comparison of the density of NADPH-diaphorase-reactive neurons in the fascia dentata and Ammon's horn between 6-month and 12-month old dark Agouti rats. Dev Brain Res 107 (1998) 207-217
220. Vallebuona F., and Raiteri M. Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity. Neuroscience 57 (1993) 577-585
221. Vallebuona F., and Raiteri M. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis. Eur J Neurosci 7 (1995) 694-701
222. Van Muiswinkel F.L., Drukarch B., Steinbusch H.W.M., and De Vente J. Sustained pharmacological inhibition of nitric oxide synthase does not affect the survival of intrastriatal rat fetal mesencephalic transplants. Brain Res 792 (1998) 48
223. Vincent S.R., and Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 45 (1992) 755-784
224. Vles J.S.H., De Louw A.J., Steinbusch H., Markerink-Van Ittersum M., Steinbusch H.W.M., Blanco C.E., Axer H., Troost J., and De Vente J. Localization and age-related changes of nitric oxide- and ANP-mediated cyclic-GMP synthesis in rat cervical spinal cord: an immunocytochemical study. Brain Res 857 (2000) 219-234
225. Waldman S.A., and Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 39 (1987) 163-196
226. Wang H., and Morris J.F. Presence of neuronal nitric oxide synthase in the suprachiasmatic nuclei of mouse and rat. Neuroscience 74 (1996) 1059-1068
227. Wang X., and Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 68 (1997) 443-456
228. Wedel B.J., and Garbers D.L. New insights on the functions of the guanylyl cyclase receptors. FEBS Lett 410 (1997) 29-33
229. Wedner H.J., Hoffer B.J., Battenberg E., Steiner A.L., Parker C.W., and Bloom F.E. A method for detecting intracellular cyclic adenosine monophosphate by immunofluorescence. J Histochem Cytochem 20 (1972) 293-299
230. Wei J.W., Chang C.M., and Chang L.W. Differential responses in cyclic GMP formation induced by excitatory amino acids (EAA) and sodium nitroprusside (SNP) in various regions of the rat brain and of rats of varied age. Int J Biochem 25 (1993) 1579-1585
231. Weinberg R.J., Valtschanoff J.G., Zabel U., and Schmidt H.H.H.W. Immunocytochemical localization of soluble guanylyl cyclase in the rat brain. Soc Neurosci Abstr 24 (1998) 242-244
232. Williams C.V., Nordquist D., and McLoon S.C. Correlation of nitric oxide synthase expression with changing patterns of axonal projections in the developing visual system. J Neurosci 14 (1994) 1746-1755
233. Wood J., and Garthwaite J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology 33 (1994) 1235-1244
234. Wood P.L., Emmett M.R., and Wood J.A. Involvement of granule, basket and stellate neurons but not Purkinje or Golgi cells in cerebellar cGMP increases in vivo. Life Sci 54 (1994) 613-620
235. Wörl J., Wiesand M., Mayer B., Greskötter K.R., and Neuhuber W.L. Neuronal and endothelial nitric oxide synthase immunoreactivity and NADPH-diaphorase staining in rat and human pancreas: influence of fixation. Histochemistry 102 (1994) 353-364
236. Wörtwein G., Gustafson B., Hansen K.L., and Mogensen J. Behavioral symptoms in adult rats after postnatal l-nitro-arginine. Int J Dev Neurosci 15 (1997) 147-154
237. Wu H.H., Williams C.V., and McLoon S.C. Involvement of nitric oxide in the elimination of a transient retinotectal projection in development. Science 265 (1994) 1593-1596
238. Xu Z.Q.D., De Vente J., Steinbusch H.W.M., Grillner S., and Hökfelt T. The NO-cGMP pathway in the rat locus coeruleus: electrophysiological, immunohistochemical and in situ hybridization studies. Eur J Neurosci 10 (1998) 3508-3516
239. Yan C., Bentley J.K., Sonnenburg W.K., and Beavo J.A. Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J Neurosci 14 (1994) 973-984
240. Yan X.X., Garey L.J., and Jen L.S. Development of NADPH-diaphorase activity in the rat neocortex. Dev Brain Res 79 (1994) 29-38
241. Yang Q., Paskind M., Bolger G., Thompson W.J., Repaske D.R., Cutler L.S., and Epstein P.M. A novel cyclic GMP stimulated phosphodiesterase from rat brain. Biochem Biophys Res Commun 205 (1994) 1850-1858
242. Zabel U., Weeger M., La M., and Schmidt H.H.H.W. Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem J 335 (1998) 51-57
243. Zabel U., Häusler C., Weeger M., and Schmidt H.H.H.W. Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione S-transferase affinity tag. J Biol Chem 274 (1999) 18149-18152
244. Zhuo M., Laitinen J.T., Li X.C., and Hawkins R.D. On the respective roles of nitric oxide and carbon monoxide in long-term potentiation in the hippocampus. Learn Mem 5 (1998) 467-480
245. Zufall F., Shepherd G.M., and Barnstable C.J. Cyclic nucleotide gated channels as regulators of CNS development and plasticity. Curr Opin Neurosci 7 (1997) 404-412
246. Zwiller J., Ghandour M.S., Revel M.D., and Basset P. Immunohistochemical localization of guanylate cyclase in rat cerebellum. Neurosci Lett 23 (1981) 31-36